632 related articles for article (PubMed ID: 11119018)
1. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
[TBL] [Abstract][Full Text] [Related]
3. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients.
Kesavulu MM; Kameswararao B; Apparao Ch; Kumar EG; Harinarayan CV
Diabetes Metab; 2002 Feb; 28(1):20-6. PubMed ID: 11938024
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus.
Ruiz C; Alegría A; Barberá R; Farré R; Lagarda MJ
Scand J Clin Lab Invest; 1999 Apr; 59(2):99-105. PubMed ID: 10353323
[TBL] [Abstract][Full Text] [Related]
5. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
6. Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes.
Gordon LA; Morrison EY; McGrowder DA; Young R; Fraser YT; Zamora EM; Alexander-Lindo RL; Irving RR
BMC Complement Altern Med; 2008 May; 8():21. PubMed ID: 18477407
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus.
Turk HM; Sevinc A; Camci C; Cigli A; Buyukberber S; Savli H; Bayraktar N
Acta Diabetol; 2002 Sep; 39(3):117-22. PubMed ID: 12357295
[TBL] [Abstract][Full Text] [Related]
8. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of oxidative stress in patients with diabetes mellitus type II -- impact of acute exercise.
Kostić N; Caparević Z; Marina D; Ilić S; Radojković J; Cosić Z; Bakić-Celić V
Vojnosanit Pregl; 2009 Jun; 66(6):459-64. PubMed ID: 19583144
[TBL] [Abstract][Full Text] [Related]
10. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients.
Peuchant E; Delmas-Beauvieux MC; Couchouron A; Dubourg L; Thomas MJ; Perromat A; Clerc M; Gin H
Diabetes Care; 1997 Feb; 20(2):202-7. PubMed ID: 9118775
[TBL] [Abstract][Full Text] [Related]
11. Serum markers of oxidative stress and severity of diabetic retinopathy.
Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
[TBL] [Abstract][Full Text] [Related]
12. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.
Evereklioglu C; Er H; Doganay S; Cekmen M; Turkoz Y; Otlu B; Ozerol E
Doc Ophthalmol; 2003 Mar; 106(2):129-36. PubMed ID: 12678277
[TBL] [Abstract][Full Text] [Related]
14. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
Katoh K
Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
[TBL] [Abstract][Full Text] [Related]
15. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
[TBL] [Abstract][Full Text] [Related]
16. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity.
Bandeira Sde M; Guedes Gda S; da Fonseca LJ; Pires AS; Gelain DP; Moreira JC; Rabelo LA; Vasconcelos SM; Goulart MO
Oxid Med Cell Longev; 2012; 2012():819310. PubMed ID: 23259029
[TBL] [Abstract][Full Text] [Related]
17. Relationship of lipid peroxides to diabetic complications. Comparison with conventional laboratory tests.
Armstrong D; Abdella N; Salman A; Miller N; Rahman EA; Bojancyzk M
J Diabetes Complications; 1992; 6(2):116-22. PubMed ID: 1611135
[TBL] [Abstract][Full Text] [Related]
18. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans.
Olusi SO
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1159-64. PubMed ID: 12187391
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of some biochemical changes in diabetic patients.
Abou-Seif MA; Youssef AA
Clin Chim Acta; 2004 Aug; 346(2):161-70. PubMed ID: 15256317
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]